[Other] Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

Dan886 Post time Yesterday 23:46 | Show all posts |Read mode
This post will be closed automatically in 2026-06-15 23:46
Reward20points

journalㄩJournal of Clinical Oncology

AuthorsㄩEva Versteijne; Jacob L. van Dam; Mustafa Suker; Quisette P. Janssen; Karin Groothuis; Janine M. Akkermans-Vogelaar; Marc G. Besselink; Bert A. Bonsing; Jeroen Buijsen; Olivier R. Busch; Geert-Jan M. Creemers; Ronald M. van Dam; Ferry A. L. M. Eskens; Sebastiaan Festen; Jan Willem B. de Groot; Bas Groot Koerkamp; Ignace H. de Hingh; Marjolein Y. V. Homs; Jeanin E. van Hooft; Emile D. Kerver; Saskia A. C. Luelmo; Karen J. Neelis; Joost Nuyttens; Gabriel M. R. M. Paardekooper; Gijs A. Patijn; Maurice J. C. van der Sangen; Judith de Vos-Geelen; Johanna W. Wilmink; Aeilko H. Zwinderman; Cornelis J. Punt; Geertjan van Tienhoven; Casper H. J. van Eijck;  

Published dateㄩ2022-4-10

DOIㄩ10.1200/jco.21.02233

PDF linkㄩhttps://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.02233

Article linkㄩhttps://doi.org/10.1200/jco.21.02233

Article SourceㄩAmerican Society of Clinical Oncology (ASCO)


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    9922


Daily Top Contributors

Return to the list